Journal
STEM CELL RESEARCH
Volume 61, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2022.102743
Keywords
-
Funding
- Japan Society for the Promotion of Science (JSPS) [12 J09944]
- Kanazawa Medical University [11181, 26699]
Ask authors/readers for more resources
This study reprogrammed peripheral blood mononuclear cells from a patient with hereditary hemorrhagic telangiectasia type 2, using episomal vectors, in order to establish an in vitro model for the disease.
Telangiectasia, hereditary hemorrhagic, type 2 (HHT2) is a rare autosomal dominant disease caused by a mutated ACVRL1 gene (Letteboer et al., 2005). The peripheral blood mononuclear cells (PBMCs) from a patient carrying a heterozygous 2 bp duplication in intron 6 of the ACVRL1 gene, NG_009549.1(NM_000020.2): c.772 + 3_772 + 4dup, were reprogrammed using episomal vectors. The inserted mutation in ACVRL1 will causes the abnormal splicing, which will be associated with HHT2. The cell line will enable proper in vitro disease modelling of HHT2(Roman and Hinck, 2017).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Recommended
No Data Available